Carla Molist

BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathways

Luz Jubierre, Aroa Soriano, Laura Planells‐Ferrer et al. · Oncogene · 2016 · 93 citations

Life Sciences, Cell Biology, Oncology +9

MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes

Aroa Soriano, Laia París-Coderch, Luz Jubierre et al. · Oncotarget · 2016 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +17

Ligand-dependent Hedgehog pathway activation in Rhabdomyosarcoma: the oncogenic role of the ligands

Ana Almazán-Moga, Patricia Zarzosa, Carla Molist et al. · British Journal of Cancer · 2017 · 34 citations · Full text

Medicine, Oncology, Pharmacology +17

miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma

Carla Molist, Natalia Navarro, Irina Giralt et al. · Cancer Letters · 2020 · 28 citations

Life Sciences, Molecular Biology, Oncology +13

Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma

Natalia Navarro, Carla Molist, Júlia Sansa-Girona et al. · Cellular and Molecular Life Sciences · 2022 · 13 citations · Full text

Medicine, Cancer Biology, Oncology +16